Literature DB >> 21295891

Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.

Hardik S Bodiwala1, Sudeep Sabde, Debashis Mitra, Kamlesh Kumar Bhutani, Inder Pal Singh.   

Abstract

Naturally occurring protoberberine alkaloids, berberine and berberrubine along with 9-substituted derivatives of berberine were assessed for the anti-human immunodeficiency virus (HIV) activity. Berberine was found to be the most active compound with an EC(50) of 0.13 μM against HIV-1 NL4.3 virus in CEM-GFP cell lines. Berberrubine and two other compounds were found to be less active than berberine, at the same time they were less toxic than berberine. Enzyme based assay suggested that the anti-HIV activity of berberine and its analogs might be due to RTase inhibitory activity and some additional mechanisms.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295891     DOI: 10.1016/j.ejmech.2011.01.016

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Safe-in-Man Broad Spectrum Antiviral Agents.

Authors:  Rouan Yao; Aleksandr Ianevski; Denis Kainov
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Sensitization of Candida albicans to terbinafine by berberine and berberrubine.

Authors:  Pikling Lam; Stanton Hon Lung Kok; Kenneth Ka Ho Lee; Kim Hung Lam; Desmond Kwok Po Hau; Wai Yeung Wong; Zhaoxiang Bian; Roberto Gambari; Chung Hin Chui
Journal:  Biomed Rep       Date:  2016-02-23

3.  Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects.

Authors:  Bhupendra Mistry; Rahul V Patel; Young-Soo Keum; Doo Hwan Kim
Journal:  Saudi J Biol Sci       Date:  2015-09-05       Impact factor: 4.219

4.  Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuAAC "click" chemistry as potential anticancer agents.

Authors:  Xin Jin; Tian-Hua Yan; Lan Yan; Qian Li; Rui-Lian Wang; Zhen-Lin Hu; Yuan-Ying Jiang; Qing-Yan Sun; Yong-Bing Cao
Journal:  Drug Des Devel Ther       Date:  2014-08-06       Impact factor: 4.162

5.  Berberine Restricts Coxsackievirus B Type 3 Replication via Inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation In Vitro.

Authors:  Qian Dai; Di Zhang; Hua Yu; Wei Xie; Rong Xin; Lei Wang; Xiaohui Xu; Xiaomei He; Junzhi Xiong; Halei Sheng; Le Zhang; Kebin Zhang; Xiaomei Hu
Journal:  Med Sci Monit       Date:  2017-03-25

Review 6.  Antiviral activity of berberine.

Authors:  Alicja Warowicka; Robert Nawrot; Anna Goździcka-Józefiak
Journal:  Arch Virol       Date:  2020-06-28       Impact factor: 2.574

7.  Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents.

Authors:  Lei Zhang; Jingjing Li; Fei Ma; Shining Yao; Naisan Li; Jing Wang; Yongbin Wang; Xiuzhen Wang; Qizheng Yao
Journal:  Molecules       Date:  2012-09-25       Impact factor: 4.411

8.  Antimicrobial characteristics of Berberine against prosthetic joint infection-related Staphylococcus aureus of different multi-locus sequence types.

Authors:  Jiaqi Tan; Jin Wang; Chuang Yang; Chongzun Zhu; Geyong Guo; Jin Tang; Hao Shen
Journal:  BMC Complement Altern Med       Date:  2019-08-16       Impact factor: 3.659

9.  Binding of the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs to tRNA(phe.).

Authors:  Anirban Basu; Parasuraman Jaisankar; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Study on the interaction of β-cyclodextrin and berberine hydrochloride and its analytical application.

Authors:  Baoxiu Jia; Yuqin Li; Decai Wang; Rui Duan
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.